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SUMMARY 
The delivery of neurotransmitter receptors into the synaptic membrane is essential for 
synaptic function and plasticity. However, the molecular mechanisms of these specialized 
trafficking events and their integration with the intracellular membrane transport machinery are 
virtually unknown. Here, we have investigated the role of the Rab family of membrane sorting 
proteins in the late stages of receptor trafficking into the postsynaptic membrane. We have 
identified Rab8, a vesicular transport protein associated to trans-Golgi network membranes, as a 
critical component of the cellular machinery that delivers AMPA-type glutamate receptors into 
synapses. Using electron microscopic techniques, we have found that Rab8 is localized in close 
proximity to the synaptic membrane, including the postsynaptic density. Electrophysiological 
studies indicated that Rab8 is necessary for the synaptic delivery of AMPA receptors during 
plasticity (long-term potentiation) and during constitutive receptor cycling. In addition, Rab8 is 
required for AMPA receptor delivery into the spine surface, but not for receptor transport from 
the dendritic shaft into the spine compartment or for delivery into the dendritic surface. 
Therefore, Rab8 drives specifically the local delivery of AMPA receptors into synapses. These 
results demonstrate a new role for the cellular secretory machinery in the control of synaptic 
function and plasticity directly at the postsynaptic membrane. 
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INTRODUCTION 
Synaptic plasticity is critical for the establishment and maturation of functional neuronal 
circuits in the brain and is widely thought of as the cellular process responsible for learning and 
memory. An important mechanism controlling synaptic maturation and remodeling is the 
targeting and delivery of neurotransmitter receptors into synapses. However, very little is known 
of the exocytic processes that sort neurotransmitter receptors into the postsynaptic membrane. In 
addition, it remains to be determined how these specialized trafficking events are integrated with 
the intracellular membrane transport machinery. In fact, most of our current knowledge on 
membrane trafficking at the synapse derives from studies on neurotransmitter vesicle fusion at 
the presynaptic terminal (reviewed in (1,2)). 
The AMPA-type glutamatergic receptors (AMPARs) are highly dynamic components of 
excitatory synapses. They can traffic in and out of the synaptic membrane constitutively or in an 
activity-dependent manner, and this regulated trafficking is known to contribute to synaptic 
plasticity during brain development and in adulthood (3-6). AMPARs are hetero-oligomeric 
molecules composed of different combinations of GluR1 to GluR4 subunits (7). In hippocampus, 
AMPARs containing GluR1 or GluR4 subunits are delivered to synapses in an activity-
dependent manner upon NMDA receptor activation, leading to long-lasting synaptic potentiation 
(8-11). In contrast, AMPARs containing only GluR2 and GluR3 subunits cycle continuously in 
and out of synapses in a manner largely independent from synaptic activity (10,12), but 
dependent on NSF (13-15) and Hsp90 (16) function. These two distinct trafficking routes have 
been coined as regulated and constitutive pathways, respectively (17). However, the cellular and 
molecular mechanisms mediating membrane transport in these pathways are largely unknown. 
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Members of the Rab family of small GTPases are important regulators of intracellular 
membrane sorting in eukaryotes. In particular, they are proposed to mediate membrane transport 
specificity (18-20). Rab proteins are likely to be important for neuronal function, since 
alterations in Rab protein regulation can lead to mental retardation in humans (21). Rab3 is a 
presynaptic member of this family (22). It controls the fusion of neurotransmitter vesicles with 
the plasma membrane (23,24) and mediates some presynaptic forms of synaptic plasticity 
(25,26). In contrast, the potential role of Rab proteins in neurotransmitter receptor targeting and 
synaptic function at the postsynaptic terminal has never been tested. 
Besides Rab3, three members of the Rab family are involved in exocytic delivery into the 
plasma membrane: Rab4, Rab8 and Rab11. In neurons, Rab8 has an exclusive somatodendritic 
distribution (27). In epithelial (28,29) and photoreceptor (30,31) cells, Rab8 mediates the 
transport of trans-Golgi network-derived membranes into specific compartments of the plasma 
membrane. Rab4 is involved in the recycling pathway from early endosomes back into the 
plasma membrane, whereas Rab11 mediates membrane transport from late endosomes and trans-
Golgi network (32-39). These three Rab proteins act on late stages of the exocytic trafficking 
into the plasma membrane, and therefore, are attractive candidates to mediate receptor targeting 
into the postsynaptic membrane. 
In this study, we have explored the role of these exocytic Rab proteins in synaptic 
function and plasticity, and in particular, in the late trafficking events that deliver AMPARs into 
synapses. Using a combination of molecular biology, electrophysiology and imaging techniques 
on organotypic hippocampal slice cultures, we have found that Rab8, but not Rab4 or Rab11, are 
required for the late stages of AMPAR synaptic delivery into the postsynaptic membrane. 
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EXPERIMENTAL PROCEDURES 
 
Constructs of recombinant proteins and expression. Rab8a, Rab4a and Rab11a coding 
sequences were cloned by PCR from a commercial rat brain cDNA preparation (Clontech, cat. # 
7150). The rat Rab8a sequence that we cloned has 96% and 97% identity to the mouse and 
human sequences, respectively. The reported Rab8a rat sequence in the NCBI database 
(accession numbers M83675 and NM_053998) has a significant N-terminal truncation (83 amino 
acids) with respect to the mouse and human sequences and with respect to the rat sequence we 
cloned. This is probably due to a sequencing error in the rat sequence submitted originally. Our 
cloned Rab4a sequence was identical to the reported rat Rab4a sequence in the NCBI database 
(accession number P05714) with the exception of two differences: Q47S and T75R. These two 
amino acids in our sequence (47S) and (75R) are conserved in the mouse and human sequences 
reported in the NCBI database (accession numbers NP_033029 and NP_004569, respectively). 
Therefore, these two differences probably correspond to sequencing errors in the previously 
reported rat sequence. Our cloned Rab11a sequence was identical to the reported one in the 
NCBI database (accession number NM_031152). Rab8a, Rab4a and Rab11a coding sequences 
were cloned as fusion proteins downstream from EGFP using the pEGFP-C1 plasmid (Clontech, 
cat. # 6084). The dominant negative mutants (GDP-bound form) were generated by PCR 
introducing a single-amino acid substitution previously described (T22N for Rab8dn, S22N for 
Rab4dn and S25N for Rab11dn). The RFP fusion construct of Rab8dn was generated with a red 
fluorescence protein variant (tdimer2(12); (40)) generously provided by Dr. Roger Tsien 
(UCSD). All constructs were recloned into pSinRep5 for Sindbis virus preparation (41). 
Hippocampal slices are prepared from young rats (postnatal day 5 to 7) and placed in culture on 
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semiporous membranes (42). After 4-7 days in culture, the recombinant gene is delivered into the 
slices. For the experiments shown in Fig. 3A and B, Fig. 4, Fig. 5B and C and Fig. 7, we used the 
biolistic delivery method (43), which allowed us to co-express several proteins with plasmids 
bearing the CMV promoter. For the rest of the experiments we use the Sindbis virus expression 
system (44). This is a replication-deficient, low-toxicity, neurotropic virus, allowing the 
expression of recombinant proteins exclusively in neurons by injecting the viral solution 
extracellularly in the desired area of a hippocampal slice (41). Expression of the recombinant 
proteins was for 36 hours when AMPA receptor subunits were expressed (Fig. 3A and B, Fig. 4 
and Fig. 7), or for 15 hours in the rest of the cases. Neurons remain morphologically and 
electrophysiologically intact during these expression times. All biosafety procedures and animal 
care protocols were approved by the University of Michigan. 
 
Electrophysiology. Simultaneous double whole-cell recordings were obtained from nearby pairs 
of infected and uninfected CA1 pyramidal neurons, under visual guidance using fluorescence 
and transmitted light illumination. The recording chamber was perfused with 119 mM NaCl, 2.5 
mM KCl, 4 mM CaCl2, 4 mM MgCl2, 26 mM NaHCO3, 1 mM NaH2PO4, 11 mM glucose, 0.1 
mM picrotoxin, 10 µM bicuculline and 2 µM 2-chloroadenosine, at pH 7.4, gassed with 5% 
CO2/95% O2. Patch recording pipettes (3-6 MΩ) were filled with 115 mM cesium 
methanesulfonate, 20 mM CsCl, 10 mM HEPES, 2.5 mM MgCl2, 4 mM Na2ATP, 0.4 mM 
Na3GTP, 10 mM sodium phosphocreatine and 0.6 mM EGTA at pH 7.25. In the rectification 
experiments, i.e. Fig 7, 0.1 mM spermine was added. Voltage-clamp whole-cell recordings were 
carried out with multiclamp 700A amplifiers (Axon Instruments, Union City, California, USA). 
Synaptic responses were evoked with two bipolar electrodes with single voltage pulses (200 µs, 
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up to 20 V). The stimulating electrodes were placed over Schaffer collateral fibers between 300 
µm and 500 µm from the recorded cells. Since only CA1, but not CA3 cells are infected, this 
configuration ensures that recombinant proteins are always expressed exclusively in postsynaptic 
cells. Synaptic AMPA receptor-mediated responses were measured at –60 mV and NMDA 
receptor-mediated responses at +40 mV and were averaged over 50-100 trials. In the rectification 
experiment (Fig 7), NMDA receptor-mediated responses were blocked pharmacologically using 
0.1 mM DL-APV. Synaptic AMPA receptor-mediated responses were measured at –60 mV and 
+40 mV and their ratio was used as an index of rectification. LTP experiments were carried out 
as previously described (16), by pairing 0 mV postsynaptic depolarization with 3 Hz presynaptic 
stimulation (300 pulses). 
 
Biochemistry. Hippocampal extracts were prepared in homogenization buffer containing 
protease inhibitors (10 mM HEPES, 500 mM NaCl, 10 mM EDTA, 4 mM EGTA, 0.1 mM 
phenylmethylsulfonyl fluoride, 2 µg/ml chymostatin, 2 µg/ml leupeptin, 2 µg/ml antipain, 2 
µg/ml pepstatin and 1% triton X-100) as previously described (8). Expression of Rab proteins 
was analyzed by Western blot with anti-Rab4 (BD Biosciences), anti-Rab8 (Pharmingen) and 
anti-Rab11 (Zymed Laboratories) antibodies. Phosphorylation of αCaMKII at Thr286 was 
analyzed with phospho-specific and regular anti-αCaMKII antibodies (Upstate) using the 
homogenization buffer described above supplemented with phosphatase inhibitors (10 mM NaF, 
1 µM microcystin LR and 0.5 µM calyculin A). 
 
Fluorescence immunohistochemistry. Immunohistochemical detection of recombinant AMPA 
receptors was carried out with anti-GFP mouse antibody (Roche). Fluorescence labeling was 
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achieved with anti-mouse biotinylated secondary antibody (Sigma) and streptavidin tagged with 
AlexaFluor 594 (Molecular Probes; Fig. 3) or with Cy5 (Amersham Biosciences; Fig. 4). 
Detergents were omitted in all incubations to evaluate surface expression. Images were taken 
using Olympus FV 500 confocal microscopy. A 60 X lens with water immersion interface was 
used. FluoView software was used for acquiring the images. ImageJ was used for 3D 
reconstruction and quantification of fluorescence intensities. Analysis of surface immunostaining 
at spines and dendrites was carried out as follows. Line plots of fluorescence intensity were 
generated across spine heads and the adjacent dendritic shafts. Fluorescence intensity at each 
compartment was quantified from the peaks corresponding to the spine and the dendrite after 
background subtraction (Fig. 4B). Then, surface ratios are calculated as the ratio between the 
GFP signal (total receptor) and the Cy5 signal (surface receptor). 
 
Immunogold electron microscopy. Hippocampal slices were fixed and processed for osmium-
free post-embedding immunogold labeling, essentially as previously described (45). Rab8 was 
labeled with anti-Rab8 antibody (Pharmingen) and an anti-mouse antibody coupled to 6 nm gold 
particles (Electron Microscopy Sciences). Electron micrographs were obtained with a Philips 
CM-100 transmission electron microscope and a Kodak 1.6 Megaplus digital camera. 
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RESULTS 
 
Role of Rab4, Rab8 and Rab11 in AMPA receptor-mediated synaptic transmission 
 As a first step to evaluate the role of these three exocytic Rab proteins in synaptic 
transmission, we blocked their function individually by expressing the corresponding dominant 
negative (Rab-dn) forms as GFP-fusion proteins in organotypic hippocampal slice cultures (see 
Experimental Procedures). Point mutations known to confer dominant negative (GDP-bound) 
phenotypes to these proteins have been employed in multiple occasions: Rab4(S22N) (46-48), 
Rab8(T22N) (31,49-51), Rab11(S25N) (36-39,52-55). Also, GFP-Rab fusions have been used 
successfully in numerous studies to study membrane trafficking in living cells (31,33,56-58)). 
Rab4dn-, Rab8dn- and Rab11dn-GFP were efficiently expressed in hippocampal slice cultures, 
as assayed by Western blot analysis (see left insets in Fig. 1). 
 The effect of these dominant negative proteins on AMPA and NMDA receptor function 
was evaluated by recording simultaneously from nearby infected and uninfected CA1 neurons, 
allowing direct comparison of synaptic responses evoked by stimulating the Schaffer collateral 
pathway from the CA3 region. Importantly, only CA1 but not CA3 cells express the recombinant 
dominant negative protein, and therefore, the site of action of these proteins when monitoring 
CA3-to-CA1 synaptic transmission is necessarily postsynaptic. As shown in Fig. 1A, Rab8dn 
significantly depressed AMPAR-mediated currents, without affecting NMDAR-mediated 
currents. Other electrophysiological parameters were not significantly different between 
uninfected and Rab8dn-infected neurons (input resistance: 168±23 MΩ -uninfected-, 192±25 
MΩ -infected-; holding current: -68±13 pA –uninfected-, -57±9 pA –infected-). This result 
suggests that Rab8 function is required for AMPAR delivery into synapses. In contrast, neither 
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Rab4dn (Fig. 1B) nor Rab11dn (Fig. 1C) changed significantly AMPAR or NMDAR-mediated 
synaptic responses. Furthermore, a dominant negative form of the endocytic Rab5 protein 
(S34N) did not alter AMPA or NMDA transmission either (unpublished observations). These 
results serve to verify that the depression of AMPAR responses by Rab8dn was not due to virus 
infection or non-specific sequestration of regulatory proteins, like GDP/GTP exchange factors 
(GEFs) or GDP dissociation inhibitors (GDIs). 
To determine whether Rab8 is a rate-limiting factor for AMPAR delivery, we 
overexpressed Rab8wt (Fig. 1D, left inset) and compared AMPA and NMDA R-mediated 
responses from control and infected nearby neurons. As shown in Fig. 1D, overexpression of 
Rab8wt did not produce any significant effect on AMPA or NMDA receptor-mediated synaptic 
transmission. Since Rab8wt overexpression did not increase AMPA currents, this result suggests 
that Rab8 is not rate-limiting for AMPAR delivery into synapses. 
 
Expression and ultrastructural localization of Rab8 in hippocampal neurons. 
The electrophysiological experiments shown above suggest a role for Rab8 in AMPA 
receptor synaptic trafficking. To further investigate this possibility, we determined the 
ultrastructural localization of Rab8 in hippocampal neurons from brain tissue. Although previous 
studies have localized Rab8 at the somatodendritic compartment in dissociated neuronal cultures 
(27), its localization relative to synaptic contacts has not been addressed before. To this end, we 
used post-embedding anti-Rab8 immunogold labeling on the synaptic region of the CA1 
hippocampus (stratum radiatum; see Experimental Procedures). Rab8 was abundant in 
postsynaptic terminals (Fig. 2A, arrows; Fig. 2B, “Postsynaptic”), whereas the presynaptic 
labeling was marginal (Fig. 2B, “Pre-”). Quantification of the immungold particles in the 
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postsynaptic terminal indicated that Rab8 accumulates in intracellular compartments in close 
proximity to the synapse (Fig. 2B, “Intra”), and in some cases directly at the postsynaptic density 
(Fig. 2B, “PSD”). This result supports a potential role for Rab8 in the local transport of 
membrane proteins into synapses. 
 We also examined Rab8wt-GFP distribution in CA1 neurons from hippocampal slices by 
imaging GFP fluorescence with confocal microscopy. Rab8wt-GFP was broadly expressed in the 
cell (Fig. 2C, left), including distal dendrites and spines (Fig. 2C, right). Although these results 
do not show specific targeting of Rab8-GFP to spines, they do suggest that the recombinant 
protein has access to membrane compartments in close proximity to synapses. 
 
Rab8 is not required for the large-scale transport of AMPA receptors along dendrites. 
Early studies using antisense oligonucleotides in dissociated neuronal cultures suggested 
that Rab8 may be involved in the export of membrane proteins from the neuronal cell body into 
dendrites (27). Therefore, it is conceivable that Rab8dn may depress AMPAR-mediated 
transmission by interfering with their transport into dendrites. We tested this possibility by 
coexpressing GFP-tagged GluR2 and Rab8dn using biolistic gene delivery (the same constructs 
and transfection method used for the electrophysiological experiments shown in Fig. 7A; see 
below). The surface distribution of the recombinant receptor was monitored by immunostaining 
using an anti-GFP antibody in non-permeabilized conditions (the GFP tag is placed at the N-
terminus of GluR2, and it is therefore exposed to the extracellular side of the plasma membrane). 
As shown in Fig. 3B, Rab8dn did not qualitatively alter the export of GluR2-GFP into the 
dendritic surface, including secondary and tertiary distal dendrites (similar to the 
immunostaining distribution obtained for GluR2-GFP expressed alone –Fig. 3A) (see Fig. 4, 
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below, for a quantitative analysis of surface receptor delivery at spines and dendrites). As 
control, neurons expressing Rab8dn-GFP alone did not show any surface immunostaining (Fig. 
3C), consistent with the intracellular distribution of Rab8. These results suggest that Rab8dn 
depresses AMPA transmission not by globally altering AMPAR transport into dendrites, but by 
interfering with a local trafficking step, possibly the synaptic delivery of the receptor. 
 
Rab8 is required for local AMPA receptor delivery into the spine surface. 
To test whether Rab8 is involved in a local step of AMPAR trafficking, we quantitatively 
evaluated the surface delivery of AMPARs at dendritic spines and their adjacent dendritic shafts. 
For this experiment we substituted the GFP tag on Rab8dn with a red fluorescence protein 
(Rab8dn-RFP, see Experimental Procedures), so its fluorescence can be separated from the 
coexpressed GluR2-GFP (the functionality of Rab8dn-RFP was confirmed electrophysiologically 
by coexpressing it with GluR2(R607Q)-GFP and monitoring receptor delivery into synapses 
using a rectification assay; see below in description for Fig. 7). Surface immunostaining was then 
carried out with an anti-GFP antibody under non-permeabilized conditions, as described above. 
In this case the labeling was visualized with an infrared fluorophore (Cy5). Therefore, this 
experimental design allows us to monitor the total amount of receptor (GFP channel), the 
fraction exposed to the cell surface (Cy5 channel) and the presence of the coexpressed Rab8dn 
(RFP channel) (see Fig. 4A as an example). 
Line plots of fluorescence intensity were generated across the spine head and the adjacent 
dendritic shaft. Surface ratios for spine and dendrites were then calculated as the ratio between 
the corresponding peaks in the Cy5 channel (surface receptor) and the GFP channel (total 
receptor) after background subtraction (see Fig. 4B). Spines are solely selected from their GFP 
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image, precluding any bias with respect to their surface immunostaining. The results of this 
analysis are shown in Fig. 4C. When expressing GluR2-GFP alone, surface ratios were similar in 
spine and dendrites. In contrast, surface ratio was significantly lower in the spines as compared 
to their adjacent dendrites when Rab8dn was coexpressed. Importantly, absolute surface ratio at 
dendrites was not altered by Rab8dn (Cy5/GFP ratios were 0.31±0.05 for GluR2 alone versus 
0.31±0.04 for GluR2 plus Rab8dn). These data indicate that Rab8dn specifically impairs the 
delivery of AMPARs to the surface of the spine. Interestingly, Rab8dn did not decrease the total 
amount of receptor (GFP channel) in the spine compared to the dendrite (Fig 4D) nor total 
receptor abundance at dendrites (absolute GFP values were 50±4 for GluR2 alone versus 54±3 
for GluR2 plus Rab8dn). These results support the interpretation that Rab8 is involved in a local 
trafficking step from an intracellular membrane compartment inside the spine to the postsynaptic 
plasma membrane. 
 
Rab8 is necessary for both the constitutive and regulated delivery of AMPA receptors into 
synapses. 
As described above, AMPARs may reach synapses through a constitutive pathway, in an 
activity-independent manner, and through a regulated pathway, triggered by NMDA receptor 
opening and CaMKII activation (17). In order to test the role of Rab8 in the constitutive 
pathway, we expressed Rab8 dominant negative in slices kept in conditions of reduced neuronal 
activity (12 mM Mg2+ was added to the culture medium immediately after infecting with the 
virus expressing Rab8dn; recordings were carried out in the presence of the standard 4 mM 
Mg2+). As shown in Fig. 5A, Rab8dn depresses AMPAR-mediated responses in conditions of 
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reduced neuronal activity, suggesting that Rab8 is necessary for the constitutive (activity-
independent) delivery of AMPARs into synapses. 
The role of Rab8 in the activity-dependent delivery of AMPARs was tested with a 
truncated form of αCaMKII (t-CaMKII) that is constitutively active (8,59). Expression of t-
CaMKII potentiated AMPAR-mediated responses (Fig. 5B), as previously described (8,59). 
However, this potentiation was fully blocked when Rab8dn was co-expressed with t-CaMKII 
(Fig. 5C). This result is consistent with Rab8 being also necessary for the regulated delivery of 
AMPARs triggered by CaMKII. To test whether the absence of potentiation is due to the 
interference of Rab8dn with CaMKII activity, we quantified the autophosphorylation levels of 
αCaMKII at Thr286 in control and Rab8dn-expressing neurons. As shown in Fig 5D, phospho-
CaMKII levels from CA1 dissected regions were similar between infected and uninfected slices. 
 
Rab8 is necessary for synaptic plasticity. 
Long term potentiation (LTP) in the CA1 hippocampus is one of the most thoroughly 
studied forms of synaptic plasticity, and it is accompanied by the synaptic delivery of GluR1-
containing AMPARs (8). To test whether Rab8 is necessary for the synaptic delivery of 
AMPARs during synaptic plasticity, we examined pairing-induced LTP in CA1 neurons infected 
with Rab8dn or Rab8wt. Consistent with its effect on CaMKII-induced AMPAR delivery, 
Rab8dn blocked LTP expression (Fig. 6). Unexpectedly, Rab8dn led to synaptic depression. This 
late depression upon LTP induction has been previously reported in situations when AMPAR 
delivery was impaired (8). Importantly, LTP was normal in cells expressing Rab8wt, as 
compared with uninfected cells (Fig. 6). These results indicate that Rab8 function is necessary 
for LTP. 
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Rab8 is necessary for the constitutive delivery of GluR2 and for the CaMKII-triggered 
delivery of GluR1 into synapses. 
In order to test directly the role of Rab8 in the pathway-specific delivery of different 
AMPAR populations into synapses, we co-expressed Rab8dn with individual recombinant 
AMPAR subunits and monitored their delivery taking advantage of their rectification properties 
(electrophysiological tagging (8-11)). The constitutive delivery of GluR2 can be assessed using 
the inwardly rectifying GluR2 mutant, GluR2 (R607Q), which does not conduct outward current 
at positive membrane potentials. Expression of this recombinant receptor produced inward 
rectification (Fig 7A; compare uninfected to GluR2(Q)), as previously described (10), indicating 
the delivery of the homomeric receptor. Co-expression of Rab8dn with GluR2 (R607Q) blocked 
this rectification (Fig. 7A), indicating that Rab8 is necessary for the constitutive delivery of 
GluR2 (similar rectification values were obtained with Rab8dn-GFP – 2.1±0.3, n=12 – and with 
Rab8dn-RFP – 2.3±0.2, n=10). As a control, co-expression of Rab8wt with GluR2 (R607Q) did 
produce rectification. This control indicates that the effect of Rab8dn was not due to insufficient 
co-expression of two recombinant proteins (see also Rab8wt control in Fig. 7B). In addition, 
Rab8dn did not produce any change in rectification if no recombinant AMPAR subunit was co-
expressed (Fig. 7A). 
The activity-dependent delivery of GluR1-containing AMPARs can be evaluated by 
using recombinant GluR1 and t-CaMKII to trigger its delivery. Co-expression of GluR1 and t-
CaMKII produced inward rectification (Fig. 7B), as previously described (8), revealing the 
delivery of homomeric GluR1. Co-expression of Rab8dn with GluR1 and t-CaMKII blocked 
rectification (Fig. 7B), indicating that Rab8 is necessary for the regulated delivery of GluR1-
containing AMPARs. 
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Rab8 is necessary for the delivery of AMPARs induced by PSD95. 
It has been recently described that overexpression of PSD95 leads to potentiation of 
AMPAR-mediated responses (60,61) in a process that is accompanied by the synaptic delivery of 
GluR1-containing receptors (62). Although the mechanisms are not completely understood, it 
has been proposed that this synaptic delivery is mediated by stargazin, which binds both PSD95 
and AMPARs (63,64). We wished to determine whether PSD95-induced delivery of AMPARs 
also requires Rab8. To this end we co-expressed recombinant GluR1, PSD95 and Rab8dn. As 
previously reported (62), co-expression of PSD95 and GluR1 leads to the delivery of 
recombinant, homomeric GluR1 receptors, producing inward rectification (Fig. 7B). However, 
when Rab8dn was co-expressed with GluR1 and PSD95, the increase in rectification was 
blocked, indicating that Rab8 is also necessary for this AMPAR delivery pathway. As control, 
co-expression of GluR1 with PSD95 and Rab8wt did show rectification (Fig. 7B), indicating that 
the absence of rectification observed with the Rab8dn is not due to inefficient co-expression of 
three proteins. 
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DISCUSSION 
The Rab family of small GTPases is known to confer directionality to intracellular 
membrane trafficking in several cell types (reviewed in (20)). However, it is surprising that very 
few studies have addressed the role of Rab proteins in neuronal function, where polarized 
membrane traffic is essential to maintain presynaptic and postsynaptic function. The notable 
exception is Rab3, which is known to regulate neurotransmitter vesicle fusion and short-term 
plasticity at the presynaptic terminal (26), although the precise mechanisms underlying this 
regulation are still being elucidated (65,66). 
We have now tested the role of the other three exocytic Rab proteins, namely Rab4, Rab8 
and Rab11, at the postsynaptic terminal. These studies have identified Rab8 as a critical player in 
postsynaptic membrane trafficking and plasticity. Rab8 was proposed to mediate dendritic 
membrane trafficking and neurite outgrowth nearly a decade ago (27,67). These early studies, 
using neuronal dissociated cultures, suggested the involvement of Rab8 in early stages of the 
secretory pathway. Since then, no reports have tested whether Rab8 plays a more direct role in 
synaptic function. Here we have shown that Rab8 is a necessary mediator of the local delivery of 
AMPARs into excitatory synapses. Using quantitative surface immunostaining, we show that 
Rab8 is required for the delivery of AMPARs into the spine surface, but not for their transport 
from the dendritic shaft into the spine compartment or for their delivery into the dendritic plasma 
membrane. In addition, by monitoring electrophysiologically the synaptic targeting of 
endogenous and recombinant AMPARs, we demonstrate that Rab8 is necessary for both the 
constitutive cycling of AMPARs and their regulated synaptic delivery, as triggered by CaMKII 
activation, PSD95 overexpression or LTP induction. Therefore, we propose that Rab8 drives the 
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local transport of AMPARs from an intracellular membrane compartment, possibly in the 
dendritic spine, to the synaptic membrane. 
Rab8 is a known mediator of exocytic transport from the trans-Golgi network into the 
plasma membrane. As such, it is possibly involved in the surface delivery of a variety of 
membrane proteins in neurons. However, an unexpected result of the present study is that Rab8 
drives the local targeting of AMPARs into the highly specialized compartment that constitutes 
the postsynaptic membrane. Several lines of evidence support this role of Rab8 in the short-range 
synaptic delivery of AMPARs. Firstly, Rab8, besides being present in the dendritic shaft, is 
localized in very close proximity to the synapse, including the postsynaptic density. Secondly, 
Rab8 is necessary for the continuous synaptic cycling of GluR2/3-containing AMPARs. 
Although the molecular details of this activity-independent pathway are not well understood, its 
fast kinetics (13,15) suggests that it occurs in close proximity to the synapse. And thirdly, 
quantitative immunohistochemical analysis showed that blockade of endogenous Rab8 function 
by expression of a Rab8 dominant negative does not affect the transport of AMPARs in 
dendrites, but it does impair receptor delivery into the spine surface. This result is in contrast 
with a previous publication showing that Rab8 was necessary for the dendritic transport of a 
recombinant viral glycoprotein (27). Although we do not know the reason for this discrepancy, it 
is possible that Rab8 plays a more general role in membrane trafficking in developing neurons, 
such as those in dissociated primary cultures, as compared with the more differentiated neurons 
present in our organotypic slice cultures. This interpretation is consistent with the proposed role 
of Rab8 in neurite outgrowth before axons and dendrites are differentiated (67). 
As mentioned above, Rab8 mediates exocytic transport from the trans-Golgi network. 
Interestingly, it has been recently described that distal dendrites contain intracellular 
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compartments belonging to the trans-Golgi network (68,69). Our functional results fit very well 
with these morphological observations, and suggest that AMPARs are driven locally from distal 
trans-Golgi network outposts into synapses via a Rab8-mediated process. Exocytic delivery of 
membrane proteins from trans-Golgi network can proceed directly into the plasma membrane or 
through intermediate recycling endosomes (29,70). Rab8 is present in both trans-Golgi network 
membranes and recycling endosomes (29), and to date, a possible role of Rab8 in controlling 
membrane sorting from both compartments has not been ruled out. Interestingly, we have found 
that Rab8 mediates both the continuous cycling of GluR2/3 receptors, and the transient, activity-
dependent delivery of GluR1/2 receptors. At this point, we cannot resolve whether these two 
populations of receptors are delivered from different intracellular compartments, or whether a 
single but sub-compartmentalized storage place is the source for both types of exocytic events. 
However, biochemical membrane fractionations (71) and imaging experiments (10,72) suggest 
that GluR1/2 and GluR2/3 receptors have different subcellular distributions. Therefore, we 
propose that the synaptic delivery of GluR1/2 receptors during synaptic plasticity is regulated 
from the trans-Golgi network, whereas the activity-independent cycling of GluR2/3 receptors 
occurs from a specialized recycling compartment in close proximity to the synapse (see Fig. 8). 
In this sense, it is important to note that neither Rab4 nor Rab11 seem to be involved in 
the continuous cycling of AMPARs (the corresponding dominant negative mutants did not affect 
basal AMPAR-mediated synaptic transmission). This observation is somehow surprising, since 
these Rab proteins are known to mediate the trafficking of various populations of recycling 
endosomes (32-36,52). Our results, then, support the interpretation that GluR2/3 synaptic 
delivery occurs from a specialized membrane compartment, whose cycling is controlled by Rab8 
but not by Rab4 or Rab11. This interpretation does not rule out a role for Rab4 and/or Rab11 in 
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other steps of AMPAR trafficking. For instance, it has been reported that AMPARs that return to 
the plasma membrane after activity-dependent internalization colocalize with Rab4-positive 
compartments (73,74). However, our results indicate that Rab8 is the Rab family member that 
directly mediates the late stages of membrane transport that result in the synaptic delivery of 
AMPARs both during constitutive receptor cycling and during activity-dependent delivery 
(LTP). 
In conclusion, these results expand our view of the cellular functions accomplished by the 
Rab protein-driven exocytic machinery in neurons, and shed light into the membrane trafficking 
events that control the dynamic organization of the postsynaptic terminal. 
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FIGURE LEGENDS: 
 
Figure 1. Rab8 is necessary for AMPA receptor delivery into synapses. (A-D) Insets, 
Western blot analysis of the expression of recombinant Rab-GFP in hippocampal slices using the 
Sindbis virus method. Big arrowheads indicate recombinant Rab-GFP proteins (about 52 KDa); 
small arrows indicate endogenous Rab proteins (about 25 KDa). Sample trace of evoked AMPA- 
and NMDA-receptor mediated synaptic responses recorded at –60 mV and +40 mV, 
respectively, from uninfected and infected cells. Scale bars, 20 pA and 40 ms. Left, average 
AMPAR-mediated current amplitude (i.e. the peak of the response recorded at –60 mV) from 
infected (inf) neurons expressing Rab8dn (A), Rab4dn (B), Rab11dn (C) or Rab8wt (D) and 
control neighboring cells not expressing the recombinant protein (uninf). n represents the number 
of pathways from cell pairs; p is the probability value according to the Wilcoxon test. Middle, 
average NMDA R-mediated current amplitude (recorded at +40 mV at a latency when AMPA 
responses are fully decayed, 60 ms) from uninfected and infected cells (n also represents the 
number of pathways from cell pairs). Right, average AMPA/NMDA ratios for uninfected and 
infected cells (n represents the number of pathways).  
 
Figure 2. Localization of Rab8 at postsynaptic terminals. (A) Ultrastructural localization of 
Rab8 at CA1 hippocampal synapses by electron microscopy. Rab8 immunogold particles 
(arrows) were found at the postsynaptic terminal, including the postsynaptic density. Labeling 
was also detected in dendritic shafts (not shown). Presynaptic terminals are labeled with 
asterisks. Scale bar, 100 nm. (B) Quantification of immunogold labeling. Most of the gold 
particles were found postsynaptically, with marginal presence presynaptically (Pre), indicating 
Rab8 controls AMPA receptor synaptic trafficking 
 29
specificity for the immunogold labeling. The majority of the gold particles were found 
intracelullarly (Intra). Gold particles were also found at the postsynaptic density (PSD) as well as 
extrasynaptic membranes (Extra). For this quantification, only gold particles within 600 nm of 
the synapse were included. (C) Rab8-GFP is present at dendritic spines. Representative confocal 
images showing the distribution of the recombinant Rab8-GFP in hippocampal neurons from 
slices. Rab8 is present in cell body and dendrites (left), as well as in dendritic spines (right). 
 
Figure 3. Immunohistochemical localization of surface AMPA receptors in slices expressing 
Rab8dn. (A) Confocal imaging of GluR2-GFP transfected neuron. GFP fluorescence signal 
(top) and surface anti-GFP immunoreactivity of the same neuron in non-permeabilized 
conditions (bottom). (B) Confocal imaging for a neuron cotransfected with GluR2-GFP and 
Rab8dn-GFP. GFP signal and surface anti-GFP immunoreactivity, as in A. (C) Control neurons 
expressing Rab8dn alone. Negative surface immunostaining (bottom) is expected given the 
intracellular distribution of Rab8-GFP. 
 
Fig. 4. Rab8dn decreases AMPAR surface delivery locally at spines. (A) Representative 
confocal image of a neuron cotransfected with GluR2-GFP and Rab8dn-RFP. Left: GFP 
fluorescence signal showing total GluR2 receptor distribution. Middle: surface GluR2-GFP 
receptors assayed by anti-GFP immunoreactivity of the same neuron in non-permeabilized 
conditions. Right: RFP fluorescence signal from the same neuron indicating expression of the 
cotransfected Rab8dn-RFP (neurons transfected only with GluR2-GFP do not show any RFP 
signal above background; not shown). Scale bar: 30 µm. (B) Representative line plot analysis of 
total (left; GFP signal) and surface (right; Cy5 signal) receptor across a spine and the adjacent 
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dendritic shaft of GluR2 transfected or GluR2 plus Rab8dn cotransfected neurons, as indicated. 
Values for surface and total receptors were taken from the fluorescence intensity peaks after 
background subtraction (dashed line). Scale bar: 2 µm. (C) Surface ratio from pairs of spines and 
dendrites in GluR2 transfected neurons (left) or in GluR2 and Rab8dn cotransfected neurons 
(middle). Surface ratios for spines and dendrites were calculated by dividing the corresponding 
background-subtracted Cy5 and GFP values. Surface ratios are normalized by the mean dendrite 
value (0.31±0.05 for GluR2 alone and 0.31±0.04 for GluR2 plus Rab8dn). Cumulative 
probabilities (right) of spine/dendrite ratios show a significant difference between the surface 
ratio distribution of GluR2 and GluR2 plus Rab8dn transfected neurons. For comparison, dashed 
lines indicate that 50% of the spine-dendrite pairs have less surface ratio in the spine than in the 
dendrite for cells transfected with GluR2 alone (black line: cumulative probability=0.5 for 
spine/dendrite=1). In contrast, 75% of the spine-dendrite pairs have less surface ratio in the spine 
than in the dendrite for cells cotransfected with Rab8dn (red line: cumulative probability=0.75 
for spine/dendrite=1). (D) Total receptor amount (GFP signal) in spines and dendrites are 
calculated in GluR2 transfected neurons (left) and in GluR2 plus Rab8dn cotransfected neurons 
(middle). Values are normalized by the mean obtained at dendrites (50±4 for GluR2 alone and 
54±3 for GluR2 plus Rab8dn). The cumulative probability (right) indicates that Rab8dn does not 
significantly change the total receptor distribution in spines versus dendrites. 
 
Figure 5. Rab8 is necessary for both the constitutive and regulated delivery of AMPA 
receptors into synapses. (A-C) Inset, sample trace of evoked AMPA receptor mediated synaptic 
responses recorded at –60 mV from uninfected/non-transfected and infected/transfected cells. 
Scale bars, 20 pA and 10 ms. (A) Rab8dn significantly reduced AMPA transmission in the 
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presence of high Mg2+ (12 mM MgCl2). Average current amplitude at –60 mV from uninfected 
and infected cells was 46.9±9.9 pA and 26.7±4.5 pA, respectively. n represents the number of 
pathways from cell pairs. p = 0.03, according to the Wilcoxon test. (B) Expression of t-CaMKII 
significantly increases AMPAR-mediated transmission. Non-transfected: 32.5±6.1 pA; 
transfected with t-CaMKII: 81.5±14.4 pA. p = 0.001, according to the Wilcoxon test; n 
represents the number of the pathways from cell pairs. (C) Rab8dn blocked t-CaMKII-induced 
potentiation of AMPA responses. Non-transfected: 25.0±4.2 pA; transfected with t-CaMKII and 
Rab8dn: 19.7±3.8 pA. (D) Rab8dn does not change the phosphorylation levels of CaMKII. Left, 
Western blot analysis showing the P-Thr286 αCaMKII / total αCaMKII ratios in Rab8dn-infected 
slices and uninfected slices. Each lane in the western blot is the result of pooling together 
extracts from three dissected CA1 regions. Right, Quantification by densitometric scanning of 
four independent experiments as the one shown in the left. 
 
Figure 6. Rab8 is necessary for LTP. Organotypic slice cultures were infected with virus 
expressing either Rab8wt or Rab8dn. Whole-cell recordings were established from neurons 
expressing the recombinant proteins or uninfected cells, and LTP was induced by pairing 3 Hz 
presynaptic stimulation with 0 mV postsynaptic depolarization, as previously described (8). (A) 
Pairing significantly increased AMPA receptor-mediated responses in uninfected (p = 0.002, 
paired t-test) and Rab8wt-infected (p = 0.001, paired t-test) neurons. However, pairing 
significantly decreased synaptic responses in Rab8dn expressing neurons (p = 0.001, paired t-
test). Inset, sample trace of evoked AMPA receptor-mediated synaptic responses recorded at –60 
mV before pairing (thin line) and 30 min after pairing (thick line) from control (uninfected) 
neurons or infected cells, as indicated. Scale bars, 20 pA and 10 ms. (B) Normalized steady-state 
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AMPAR response amplitudes in paired (LTP induction) and control (Unpaired) pathways in cells 
expressing Rab8wt-GFP, Rab8dn-GFP and uninfected control cells. AMPAR responses from 
control pathways were not statistically different from baseline responses. 
 
Figure 7. Rab8 is necessary for the constitutive delivery of GluR2 and for the delivery of 
GluR1 triggered by t-CaMKII or by PSD95 into synapses. Rectification values were 
calculated as the ratio between the amplitude of the synaptic response at -60 mV over the 
amplitude at +40 mV. Endogenous receptors conduct current at -60 mV and +40 mV, whereas 
recombinant receptors conduct only at negative membrane potentials. Therefore, delivery of the 
recombinant homomeric receptors is accompanied by an increase in the rectification value (a 
decrease in the outward current, depicted by the arrow head in A, with respect to the inward 
current). (A) Average rectification values were: control (uninfected), 1.9±0.2; GluR2(R586Q), 
3.3±0.2; GluR2(R586Q) plus Rab8dn, 2.1±0.3; GluR2(R586Q) plus Rab8wt, 3.3±0.2; Rab8dn, 
2.3±0.3. (B) Average rectification values were: GluR1 plus t-CaMKII, 3.9±0.7; GluR1 plus t-
CaMKII and Rab8dn, 1.8±0.2; GluR1 plus PSD95, 3.5±0.5; GluR1 plus PSD95 and Rab8dn, 
2.0±0.2; GluR1 plus PSD95 and Rab8wt, 3.5±0.4. n represents the number of pathways, p is the 
probability value according to the Student’s t-test. Inset, sample traces of evoked AMPA 
receptor mediated synaptic responses recorded at –60 mV and +40 mV from control or 
transfected cells as indicated. Scale bars, 20 pA and 20 ms. 
 
Figure 8. Membrane sorting model for the control of AMPAR synaptic delivery by Rab8. 
The regulated (activity-dependent) delivery of GluR1/2 receptors would be mediated by Rab8 
from a membrane compartment belonging to the trans-Golgi network (TGN). In contrast, the 
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continuous (activity-independent) delivery of GluR2/3 receptors would occur from specialized 
recycling endosomes (RE) whose sorting is also controlled by Rab8. 
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